ArticlePhysiological reports2026
CMR-derived left ventricular pressure-volume loops enhance individualized assessment of disease severity and prognosis in pulmonary arterial hypertension in adults.
Article in Physiological reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
In pulmonary arterial hypertension (PAH), increased pulmonary vascular resistance (PVR) causes right ventricular pressure overload and left ventricular (LV) underfilling. We investigated LV mechanics and their prognostic value in PAH using cardiovascular magnetic resonance (CMR)-derived LV pressure-volume (PV) loops. We included 96 patients (median age 64 years, 70% women) with PAH and clinically indicated CMR between 2003 and 2025, and 32 age- and sex-matched healthy controls. CMR-based LV PV-loops were computed. Right heart catheterization, brachial blood pressure, treatment, and time of death or lung transplantation were retrieved from medical records. Patients demonstrated lower stroke work (SW) and ventricular efficiency (VE), and higher contractility (Ees), arterial elastance (Ea), ventriculo-arterial coupling (VAC), and energy per ejected volume (EEV) than controls. SW and Ea correlated with PVR, VE and VAC correlated with diastolic transpulmonary gradient (p < 0.001). After 3 years median follow-up, 64 (68%) patients died or underwent lung transplantation. Supra-median SW was associated with better prognosis in patients ≤55 years. Exploratory data suggested increasing SW in treatment responders only. CMR-based PV-loops showed LV mechanics alterations in PAH. SW, VE, Ea, and VAC correlated with disease severity. SW predicted survival in patients ≤55 years and might help monitor treatment response.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.